RXST 241220 42.50P (RXST241220P42500) Stock Options, News & Quotes

US OptionsDetailed Quotes

RXST241220P42500

Watchlist

8.74
+2.94+50.69%

15min DelayClose Dec 20 16:00 ET

8.74High8.74Low

Intraday

5D
Daily

News

Sector Update: Health Care Stocks Rise in Late Afternoon Trading
MT NewswiresDec 20 15:57 ET
RxSight Down Over 13%, on Pace for Largest Percent Decrease Since June 2022 -- Data Talk
Dow JonesDec 20 15:35 ET
Stifel Downgrades RxSight(RXST.US) to Hold Rating, Cuts Target Price to $40
Moomoo NewsDec 20 13:31 ET · Ratings
Hold Rating Issued Amidst Rising Competition and Market Uncertainty for RxSight
TipRanksDec 20 12:58 ET · Ratings
RxSight Cut to Hold at Stifel on Competition Concerns
Seeking AlphaDec 20 10:43 ET
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
BenzingaDec 20 09:59 ET

Comments

Meltyy

May 16 01:19

🔔 RA Capital Q1 ‘24* Holdings Released... 🐳

» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$
...

Moomoo AI

Feb 5 04:22

The recent insider sale of RxSight shares and the absence of insider purchases over the last year raise concerns about the company's outlook. Despite significant insider ownership, the lack of insider buying does not inspire confidence in the company's prospects.

Trade Alert: Independent Director Of RxSight William Link Has Sold Stock

Iwill TradeScared

Jan 8 14:23

$RxSight (RXST.US)$ oww back in action now sold too early

Iwill TradeScared

Dec 15, 2023 18:26

$RxSight (RXST.US)$ 213 % runs looks good here priming to jump 🔥

Iwill TradeScared

Dec 14, 2023 12:38

$RxSight (RXST.US)$ bought few lets fo !